Another North American Cannabis Cannabis Co. Enters German Market

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) has introduced Cresco-branded flower in Germany. The move marks the company’s first commercial entry into the European Union.

The collaboration with Blossom, Cresco Labs’ EU GMP-certified manufacturing partner in Portugal, resulted in the launch of three signature flower products.

“After extensive work understanding the European landscape, we’re confident that Cresco can deliver meaningful value through our portfolio of market-leading brands, proven operational capabilities, and deep experience operating in dynamic regulatory environments,” Charlie Bachtell, CEO of Cresco Labs, said. “Our objective is to use these insights to guide future growth decisions in evolving markets.”

Cresco products are now accessible by prescription at licensed pharmacies across Germany.

Other North American cannabis operators that are already present in Germany are Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) and Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF), which, through its subsidiaries and business branches, operate within the country’s medical cannabis market.

The German government eased restrictions on medical cannabis use for seriously ill patients who have no other treatment options in 2016. The legislative change took effect in 2017.

The European country legalized the recreational use of cannabis as well, some eight years later, in April 2024, becoming the ninth country to do so. In the six months of 2025, imports skyrocketed, with an increase of over 400% year-over-year, the government said. That prompted the country’s cabinet to pass plans in October to restrict the online sale of cannabis the uptick in imports, according to Reuters.

CRLBF Price Action

Cresco Labs’ shares traded 2.76% lower at $1.13 per share at the time of writing on Thursday morning.